Published in J Urol on December 01, 2000
Drug-induced urinary calculi. Rev Urol (2003) 0.97
Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol (2010) 0.96
Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice. Am J Physiol Regul Integr Comp Physiol (2009) 0.91
Renal Dysfunction in HIV-1-infected Patients. Curr Infect Dis Rep (2002) 0.77
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07
Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med (1998) 11.14
FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell (1995) 9.81
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell (1995) 9.22
The receptor for the cytotoxic ligand TRAIL. Science (1997) 6.39
Screening for prostate cancer. A decision analytic view. JAMA (1994) 5.83
Meta-analysis in clinical research. Ann Intern Med (1987) 5.16
Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol (1992) 4.86
Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell (2000) 4.19
Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem (1996) 3.97
On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics (2001) 3.83
FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem (1996) 3.72
Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med (1993) 3.53
Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science (1997) 3.51
A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem (1994) 3.13
Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology (1989) 2.88
Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science (1996) 2.87
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.82
Role of CED-4 in the activation of CED-3. Nature (1997) 2.76
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem (1990) 2.37
Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem (1998) 2.25
Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21
Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol (1999) 2.19
A randomized crossover trial of Quick Medical Reference (QMR) as a teaching tool for medical interns. J Gen Intern Med (1994) 2.10
A role for FADD in T cell activation and development. Immunity (1998) 2.09
Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci U S A (1996) 1.90
Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology (1995) 1.90
A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol (1995) 1.76
Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother (1999) 1.74
Age distribution of Helicobacter pylori seroprevalence among young children in a United States/Mexico border community: evidence for transitory infection. Am J Epidemiol (1999) 1.68
Perioperative parenteral nutrition: a meta-analysis. Ann Intern Med (1987) 1.62
Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65. CMAJ (1999) 1.61
Development of Kaposi's sarcoma despite sustained suppression of HIV plasma viremia. J Acquir Immune Defic Syndr (1999) 1.59
Ritonavir and saquinavir combination therapy for the treatment of HIV infection. AIDS (1999) 1.58
Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J Biol Chem (1996) 1.57
A randomized controlled trial to assess the incidence of new onset hypertension in patients after shock wave lithotripsy for asymptomatic renal calculi. J Urol (1998) 1.54
Cost induced by hip fractures. Ir Med J (2008) 1.46
Preoperative fasting for preventing perioperative complications in children. Cochrane Database Syst Rev (2005) 1.45
Autoimmune encephalopathy presenting as a 'posterior circulation stroke'. J Neurol (2010) 1.45
OAS1: a multiple sclerosis susceptibility gene that influences disease severity. Neurology (2010) 1.45
Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44
Effect of cessation of highly active antiretroviral therapy during a discordant response: implications for scheduled therapeutic interruptions. Clin Infect Dis (2001) 1.44
Improving prevention in primary care: evaluating the effectiveness of outreach facilitation. Fam Pract (2008) 1.40
Thrombospondin-induced adhesion of human keratinocytes. J Clin Invest (1988) 1.33
Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.33
Predicting nutrition-associated complications for patients undergoing gastrointestinal surgery. JPEN J Parenter Enteral Nutr (1987) 1.32
Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother (2001) 1.31
Residential mobility and risk of childhood acute lymphoblastic leukaemia: an ecological study. Br J Cancer (2007) 1.30
Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. J Biol Chem (1992) 1.27
Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study. HIV Med (2012) 1.23
Cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med (1996) 1.21
Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ (1999) 1.19
A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J Biol Chem (1991) 1.15
Effectiveness of emergency medical services for victims of out-of-hospital cardiac arrest: a metaanalysis. Ann Emerg Med (1996) 1.15
Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.14
Synthesis of wild type and mutant human hemoglobins in Saccharomyces cerevisiae. Biotechnology (N Y) (1991) 1.14
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years. Clin Infect Dis (2008) 1.13
A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care (2006) 1.11
Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. Clin Exp Immunol (2012) 1.10
High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum- and anchorage-independent growth. J Biol Chem (1993) 1.09
Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum (1994) 1.09
Recurrent torsion of testis in adults. Can Med Assoc J (1978) 1.08
Acute phase responses and cytokine secretion in chronic fatigue syndrome. J Clin Immunol (1999) 1.07
"Sixteen and a half": a novel pontine neuro-ophthalmological syndrome. J Neurol (2011) 1.07
Stability of treatment preferences: although most preferences do not change, most people change some of their preferences. J Clin Ethics (1997) 1.07
Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin. Proc Natl Acad Sci U S A (1985) 1.06
The anterolateral approach leads to less disruption of the femoral head-neck blood supply than the posterior approach during hip resurfacing. J Bone Joint Surg Br (2007) 1.03
A randomized trial of a decisional aid for mental capacity assessments. J Clin Epidemiol (1993) 1.02
Anti-NMDA receptor encephalitis with associated catatonia during pregnancy. J Neurol (2012) 1.02
Differential production of IL-10 by T cells and monocytes of HIV-infected individuals: association of IL-10 production with CD28-mediated immune responsiveness. Clin Exp Immunol (1998) 1.01
Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors. Clin Infect Dis (1998) 1.01
Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity? Mucosal Immunol (2012) 1.01
Iatrogenic ureteric injuries: approaches to etiology and management. Can J Surg (1998) 0.98
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology (1996) 0.98
Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J Clin Immunol (1996) 0.95
Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis. AIDS (2000) 0.94
A prospective study of peri-diagnostic and surgical wait times for patients with presumptive colorectal, lung, or prostate cancer. Br J Cancer (2008) 0.93
Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells. Cancer Res (1995) 0.93
Development and psychometric validation of the HIV Treatment Knowledge Scale. AIDS Care (2007) 0.92
Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition (1992) 0.92
A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness. Vaccine (2011) 0.92
APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews. Gastroenterology (2001) 0.92
Hepatitis A among schoolchildren in a US-Mexico border community. Am J Public Health (1997) 0.92
A comparison of three rapid D-dimer methods for the diagnosis of venous thromboembolism. Br J Haematol (2001) 0.92
Thrombospondin binding by human squamous carcinoma and melanoma cells: relationship to biological activity. Exp Cell Res (1988) 0.91
Elevated hepatitis A and E seroprevalence rates in a Texas/Mexico border community. Tex Med (1998) 0.91
Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir J Med Sci (2010) 0.91
Postoperative analgesia after lumbar laminectomy: epidural fentanyl infusion versus patient-controlled intravenous morphine. Anesth Analg (1995) 0.89
Age-specific incidence of hip fracture in the elderly: a healthy decline. Surgeon (2010) 0.89
A review of antigenic variation by the equine infectious anemia virus. Contrib Microbiol Immunol (1987) 0.89
Ten-year review of vesical diverticula. Urology (1982) 0.89
Expression and analysis of COOH-terminal deletions of the human thrombospondin molecule. J Cell Biol (1989) 0.88
An analysis of skin perfusion over the achilles tendon in varying degrees of plantarflexion. Foot Ankle Int (2001) 0.88
Successful implementation of a national HLA-B*5701 genetic testing service in Canada. Tissue Antigens (2009) 0.87
The Brophy case: the use of artificial hydration and nutrition. Linacre Q (1987) 0.87
The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite. Mult Scler (2007) 0.86
Evaluation of short-course therapy with cefixime or rifampin for eradication of pharyngeally carried group A streptococci. The Ontario GAS Study Group. Clin Infect Dis (1995) 0.86
Risk factor analysis of peri-neonatal mortality in rural Guatemala. Bull Pan Am Health Organ (1994) 0.86